162 related articles for article (PubMed ID: 34506868)
1. Immunological perspectives on spatial and temporal vaccine delivery.
Zhu M
Adv Drug Deliv Rev; 2021 Nov; 178():113966. PubMed ID: 34506868
[TBL] [Abstract][Full Text] [Related]
2. Lymphatic-targeted cationic liposomes: a robust vaccine adjuvant for promoting long-term immunological memory.
Wang C; Liu P; Zhuang Y; Li P; Jiang B; Pan H; Liu L; Cai L; Ma Y
Vaccine; 2014 Sep; 32(42):5475-83. PubMed ID: 25110295
[TBL] [Abstract][Full Text] [Related]
3. Efficient antigen delivery to the draining lymph nodes is a key component in the immunogenic pathway of the intradermal vaccine.
Tozuka M; Oka T; Jounai N; Egawa G; Ishii KJ; Kabashima K; Takeshita F
J Dermatol Sci; 2016 Apr; 82(1):38-45. PubMed ID: 26674124
[TBL] [Abstract][Full Text] [Related]
4. Coformulation with Tattoo Ink for Immunological Assessment of Vaccine Immunogenicity in the Draining Lymph Node.
Barber-Axthelm IM; Kelly HG; Esterbauer R; Wragg KM; Gibbon AM; Lee WS; Wheatley AK; Kent SJ; Tan HX; Juno JA
J Immunol; 2021 Jul; 207(2):735-744. PubMed ID: 34244296
[TBL] [Abstract][Full Text] [Related]
5. Vaccine delivery systems toward lymph nodes.
Ding Y; Li Z; Jaklenec A; Hu Q
Adv Drug Deliv Rev; 2021 Dec; 179():113914. PubMed ID: 34363861
[TBL] [Abstract][Full Text] [Related]
6. Alum/Toll-Like Receptor 7 Adjuvant Enhances the Expansion of Memory B Cell Compartment Within the Draining Lymph Node.
Vo HTM; Baudner BC; Sammicheli S; Iannacone M; D'Oro U; Piccioli D
Front Immunol; 2018; 9():641. PubMed ID: 29686670
[TBL] [Abstract][Full Text] [Related]
7. An Albumin-binding Polypeptide Both Targets Cytotoxic T Lymphocyte Vaccines to Lymph Nodes and Boosts Vaccine Presentation by Dendritic Cells.
Wang P; Zhao P; Dong S; Xu T; He X; Chen M
Theranostics; 2018; 8(1):223-236. PubMed ID: 29290804
[No Abstract] [Full Text] [Related]
8. Lymph node targeting strategies to improve vaccination efficacy.
Jiang H; Wang Q; Sun X
J Control Release; 2017 Dec; 267():47-56. PubMed ID: 28818619
[TBL] [Abstract][Full Text] [Related]
9. Intranasal Live Influenza Vaccine Priming Elicits Localized B Cell Responses in Mediastinal Lymph Nodes.
Jegaskanda S; Mason RD; Andrews SF; Wheatley AK; Zhang R; Reynoso GV; Ambrozak DR; Santos CP; Luke CJ; Matsuoka Y; Brenchley JM; Hickman HD; Talaat KR; Permar SR; Liao HX; Yewdell JW; Koup RA; Roederer M; McDermott AB; Subbarao K
J Virol; 2018 May; 92(9):. PubMed ID: 29444938
[TBL] [Abstract][Full Text] [Related]
10. Controlling timing and location in vaccines.
Irvine DJ; Aung A; Silva M
Adv Drug Deliv Rev; 2020; 158():91-115. PubMed ID: 32598970
[TBL] [Abstract][Full Text] [Related]
11. Engineering the Deformability of Albumin-Stabilized Emulsions for Lymph-Node Vaccine Delivery.
Song T; Xia Y; Du Y; Chen MW; Qing H; Ma G
Adv Mater; 2021 Jul; 33(26):e2100106. PubMed ID: 34013604
[TBL] [Abstract][Full Text] [Related]
12. Enhancing efficacy of anticancer vaccines by targeted delivery to tumor-draining lymph nodes.
Jeanbart L; Ballester M; de Titta A; Corthésy P; Romero P; Hubbell JA; Swartz MA
Cancer Immunol Res; 2014 May; 2(5):436-47. PubMed ID: 24795356
[TBL] [Abstract][Full Text] [Related]
13. Chemokine-guided cell positioning in the lymph node orchestrates the generation of adaptive immune responses.
Lian J; Luster AD
Curr Opin Cell Biol; 2015 Oct; 36():1-6. PubMed ID: 26067148
[TBL] [Abstract][Full Text] [Related]
14. Engineering Strategies for Lymph Node Targeted Immune Activation.
Chen Y; De Koker S; De Geest BG
Acc Chem Res; 2020 Oct; 53(10):2055-2067. PubMed ID: 32910636
[TBL] [Abstract][Full Text] [Related]
15. PEGylated cationic liposomes robustly augment vaccine-induced immune responses: Role of lymphatic trafficking and biodistribution.
Zhuang Y; Ma Y; Wang C; Hai L; Yan C; Zhang Y; Liu F; Cai L
J Control Release; 2012 Apr; 159(1):135-42. PubMed ID: 22226776
[TBL] [Abstract][Full Text] [Related]
16. Beyond antigens and adjuvants: formulating future vaccines.
Moyer TJ; Zmolek AC; Irvine DJ
J Clin Invest; 2016 Mar; 126(3):799-808. PubMed ID: 26928033
[TBL] [Abstract][Full Text] [Related]
17. Clinical observations on adoptive immunotherapy with vaccine-primed T-lymphocytes secondarily sensitized to tumor in vitro.
Chang AE; Yoshizawa H; Sakai K; Cameron MJ; Sondak VK; Shu S
Cancer Res; 1993 Mar; 53(5):1043-50. PubMed ID: 8439951
[TBL] [Abstract][Full Text] [Related]
18. Enhancement of adaptive immunity by the human vaccine adjuvant AS01 depends on activated dendritic cells.
Didierlaurent AM; Collignon C; Bourguignon P; Wouters S; Fierens K; Fochesato M; Dendouga N; Langlet C; Malissen B; Lambrecht BN; Garçon N; Van Mechelen M; Morel S
J Immunol; 2014 Aug; 193(4):1920-30. PubMed ID: 25024381
[TBL] [Abstract][Full Text] [Related]
19. B-cell follicle development remodels the conduit system and allows soluble antigen delivery to follicular dendritic cells.
Bajénoff M; Germain RN
Blood; 2009 Dec; 114(24):4989-97. PubMed ID: 19713459
[TBL] [Abstract][Full Text] [Related]
20. Altered immune cell follicular dynamics in HIV infection following influenza vaccination.
Moysi E; Pallikkuth S; De Armas LR; Gonzalez LE; Ambrozak D; George V; Huddleston D; Pahwa R; Koup RA; Petrovas C; Pahwa S
J Clin Invest; 2018 Jul; 128(7):3171-3185. PubMed ID: 29911996
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
